Johnson & Johnson (JNJ) stock fundamentals
NYSE · Healthcare · Drug Manufacturers - General
USD 267.93 last price as of Tue, 27 Oct 2026 15:09 UTC
Valuation
- Market cap
- USD 644.99B
- P/E (trailing)
- 40.66
- P/E (forward)
- 23.24
- PEG ratio
- 3.02
- Price / sales
- 6.49
- Price / book
- 7.91
- EV / EBITDA
- 19.4x
- Dividend yield
- 2.01%
Profitability
- Gross margin
- 67.8%
- Operating margin
- 25.7%
- Net margin
- 16.2%
- Return on equity
- 20.0%
Growth (year over year)
- Revenue growth
- 5.9%
- Earnings growth
- -95.9%
Balance sheet & cash flow
- Total cash
- USD 17.23B
- Total debt
- USD 44.65B
- Free cash flow
- USD 18.50B
- Current ratio
- 1.02
Price range
- 52-week low
- USD 184.66
- 52-week high
- USD 281.07
About Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through…
Employees: 138,200
Go deeper on JNJ
The free Fundamentals tool adds multi-year revenue, earnings, margin, cash flow and debt history, P/E and valuation trends, Piotroski, Altman and Beneish health scores, and dividend history. Learn how to read them in how to analyse stock fundamentals.
Other popular stocks
Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Amazon (AMZN)Alphabet (GOOGL)Meta Platforms (META)Tesla (TSLA)Broadcom (AVGO)Berkshire Hathaway (BRK-B)JPMorgan Chase (JPM)Visa (V)Mastercard (MA)Eli Lilly (LLY)UnitedHealth (UNH)Exxon Mobil (XOM)Costco (COST)Walmart (WMT)Netflix (NFLX)AMD (AMD)Palantir (PLTR)Oracle (ORCL)Salesforce (CRM)Adobe (ADBE)Intel (INTC)
Data from company filings (SEC EDGAR) and market data providers; it may be delayed or contain errors. Draw The Line Pro provides general market information and education only. Nothing on this page is personal financial advice or a recommendation to buy or sell any security.